Skip to content
Home/Companies/MedTech/Phagenesis
PH

Phagenesis

MedTech·UK·Active·2yr hold

Phagenesis is a MedTech company, headquartered in UK.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns Phagenesis?

Phagenesis is currently owned by Northern Gritstone through Northern Gritstone Evergreen (2020 vintage), since 2024.

Hand-verified · updated 2026-06-02

Northern Gritstone
Investor
Northern Gritstone
Northern Gritstone Evergreen · 2020 · Evergreen

Key facts

HQUK
SectorMedTech
StatusActive

More from Northern Gritstone Evergreen

Other portfolio companies in the same fund.

AmpliSi
Active
Deep TechUK· 2026
Cytotrait
Active
AgTechUK· 2026
Apini Therapeutics
Active
BiotechUK· 2025
IVFmicro
Active
MedTechUK· 2025
Literal Labs
Active
AI/MLUK· 2025
OLO Robotics
Active
Deep TechUK· 2025

More PE-backed in MedTech

Comparable medtech deals from other GPs.

Lattice Medical
Active
Finovam GestionFrance
QTAS
Active
OVNI CapitalGermany
Serres
Active
G Square Healthcare PEFinland· 2026
Stago
Active
ARCHIMEDFrance· 2026
Amoena
Active
Apera Asset ManagementGermany· 2025
Amotio
Active
Development Bank of WalesUK· 2025
Data refreshed weekly · Sourced from public filings